More info:

• Popular Products

  Viagra Cialis Viagra Professional Cialis Professional Amoxil Prednisolone Lasix Propecia Levitra

• Androxal: Restoring Endogenous Testosterone for Hypogonadism - An Evidence-Based Review

  Product Description: Androxal is the brand name for enclomiphene citrate, a selective estrogen receptor modulator (SERM) administered orally. It is distinct from its isomer, zuclomiphene, which is found in the commonly prescribed fertility drug clomiphene citrate. Androxal acts centrally at the hypothalamus to stimulate the body’s own production of testosterone and sperm, positioning it as a potential therapeutic alternative to exogenous testosterone replacement therapy (TRT) for men with specific endocrine disorders.

• Enclomisign: Stimulating Endogenous Testosterone for Hypogonadism - Evidence-Based Review

  Product Description: Enclomisign is a novel, non-hormonal oral compound classified as a selective estrogen receptor modulator (SERM) with a unique profile. It is being developed and studied primarily as a potential therapeutic agent for the management of male hypogonadism, specifically aiming to increase endogenous testosterone production without the typical suppression of the hypothalamic-pituitary-gonadal (HPG) axis associated with exogenous testosterone or the estrogenic side effects of classic SERMs like clomiphene citrate. Its core mechanism revolves around antagonizing estrogen receptors in the hypothalamus, thereby blocking the negative feedback of estrogen and stimulating the pulsatile release of gonadotropin-releasing hormone (GnRH), followed by luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary.

• Fertogard: Comprehensive Nutritional Support for Fertility Optimization - Evidence-Based Review

  Product Description for Healthcare Professional Review Fertogard is a comprehensive, evidence-based dietary supplement system designed to address foundational nutritional and metabolic factors in both male and female fertility. It operates on the principle that optimal gametogenesis and reproductive function require specific micronutrient cofactors, antioxidant protection, and hormonal milieu support. The system is typically divided into male and female formulations, each tailored to the distinct physiological demands of sperm production and oocyte quality/ovulatory function.

• Fertomid: Ovulation Induction for Anovulatory Infertility - Evidence-Based Review

  Fertomid: A comprehensive, evidence-based monograph on the oral ovulation inducer clomiphene citrate. Learn about its dual-isomer mechanism of action, primary use in anovulatory infertility, and evidence-based dosing protocols. Understand key contraindications, drug interactions, and how it compares to other fertility treatments. Discover the clinical data and real-world application from a reproductive endocrinology perspective. Let’s talk about Fertomid. If you’re in the world of reproductive medicine, or you’re a patient who’s been handed this prescription after months of trying, you know it’s often the first line of defense.

• Aldactone

  Let’s talk about Aldactone. If you’ve been in practice for a while, you remember when it was just that weird diuretic that could cause gynecomastia and hyperkalemia, tucked away on the formulary for maybe the odd case of ascites. The journey of this drug from a niche agent to a cornerstone in heart failure and resistant hypertension is one of the more fascinating stories in pharmacotherapy, born out of both serendipity and rigorous science.

• Altraz: Non-Invasive Neuromodulation for Treatment-Resistant Depression - Evidence-Based Review

  Product Description: Altraz is a Class IIa medical device, specifically a non-invasive transcranial magnetic stimulation (TMS) system designed for home use under medical supervision. It employs low-intensity, patterned electromagnetic fields to modulate neural activity in the prefrontal cortex and associated limbic structures. Unlike pharmaceutical interventions, it is a neuromodulation device intended to provide a non-systemic, drug-free approach to supporting mood regulation and cognitive function in adults with Major Depressive Disorder (MDD) who have had an inadequate response to initial antidepressant therapy.

• Amoxil

  Prima di tutto, chiariamo subito di cosa stiamo parlando, perché nel gergo ospedaliero a volte si fa confusione. Amoxil è il nome commerciale, uno dei tanti in realtà, dell’amoxicillina. Non è un integratore, non è un dispositivo. È un antibiotico, punto. Un beta-lattamico, per la precisione, della famiglia delle aminopenicilline. La sua importanza nella pratica clinica quotidiana è tale che sarebbe difficile immaginare un reparto, uno studio medico o una farmacia di comunità senza di essa.

• Apcalis SX Oral Jelly: Trattamento Rapido e Discreto per la Disfunzione Erettile - Monografia Basata sull'Evidenza

  Prima di entrare nel dettaglio del documento strutturato, è fondamentale descrivere cos’è realmente questo prodotto. L’Apcalis SX Oral Jelly rappresenta un adattamento farmaceutico significativo del principio attivo Tadalafil, un inibitore della fosfodiesterasi di tipo 5 (PDE5) di seconda generazione. A differenza delle compresse tradizionali, si presenta in una formulazione gelificata orale, monodose, con diversi aromi. La sua caratteristica distintiva non è solo la via di somministrazione, ma la farmacocinetica che ne deriva: un assorbimento sublinguale e buccale più rapido, bypassando parzialmente il sistema portale epatico, il che si traduce in un inizio d’azione potenzialmente più veloce rispetto alla compressa standard.

• Arimidex (Anastrozole): Effective Estrogen Suppression for Breast Cancer Therapy - Evidence-Based Review

  Product Description: Arimidex is the brand name for the pharmaceutical compound anastrozole. It is classified as a non-steroidal aromatase inhibitor and is available as a prescription medication in tablet form. It is not a dietary supplement or an over-the-counter medical device. Its primary and approved use is in the field of oncology, specifically for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It functions by dramatically reducing the production of estrogen in the body, which can fuel the growth of certain types of breast cancer cells.